Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003000 · ClinicalTrials.gov registry record
Morphine for the Treatment of Pain in Patients With Breast Cancer
A clinical trial, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- 18
- Enrollment target
NCT00003000: Completed study, sponsored by Roswell Park Cancer Institute.
NCT00003000 is a clinical trial that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003000 has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
RATIONALE: Morphine helps to relieve the pain associated with cancer surgery. Giving morphine in different ways may offer more pain relief. PURPOSE: This randomized clinical trial is studying how well morphine injected directly into the underarm area works compared with morphine injected into the back of the shoulder in treating pain in patients who have breast cancer and who are undergoing axillary lymph node dissection.
Interventions
- DRUG morphine sulfate
- DRUG fentanyl citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 1992-05 |
| Est. Completion | 2001-06 |
What the finished NCT00003000 record still lists
NCT00003000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which morphine sulfate is the first listed.
NCT00003000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003000 about?
NCT00003000 is a clinical study titled "Morphine for the Treatment of Pain in Patients With Breast Cancer". RATIONALE: Morphine helps to relieve the pain associated with cancer surgery. Giving morphine in different ways may offer more pain relief. PURPOSE: This randomized clinical trial is studying how well morphine injected directly into the underarm area works compared with morphine injected into the b...
What is the current status of trial NCT00003000?
This trial is currently completed. The enrollment target is 18 participants. The study started on 1992-05. Estimated completion is 2001-06.
What interventions are being tested in trial NCT00003000?
The interventions under investigation include: morphine sulfate (DRUG), fentanyl citrate (DRUG).
Who is sponsoring clinical trial NCT00003000?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia